West Pharmaceutical Services, Inc. WST
Set alert
411.51 USD +3.63 +0.89%
As of Nov 3, 12:52 PM ET
406.05 Day range 416.23
230.95 52-week range 416.67
- YTD
- +49.56%
- 1 year
- +47.08%
- Open
- 407.39
- Prev close
- 407.88
- Mkt cap
- 28.67B
- Vol
- 447.60K
- Avg vol
- 584.68K
- EPS
- 7.81
- P/E
- 52.70
- Div yield
- 0.21%
More statistics
- Low
- 406.05
- High
- 416.23
- Forward P/E
- 39.53
- Beta
- 1.14
- Short ratio
- 3.38
- Inst. own
- 103.72%
- Dividend
- 1.04
- Ex-div date
- Nov 9, 2026
- Earnings
- Feb 11, 2027
- 50-d avg
- 367.60
- 200-d avg
- 313.38
- 1y target
- 466.67
3M chart
Events in this range
- Oct 7, 2026Rating: Barclays · Overweight → Overweight
- Oct 13, 2026Rating: TD Cowen · Buy → Buy
- Oct 29, 2026Earnings: 2.66; estimate 2.2; surprise 20.91%
- Oct 30, 2026Rating: Evercore ISI Group · Outperform → Outperform
- Oct 30, 2026Rating: Barclays · Overweight → Overweight
- Oct 30, 2026Rating: TD Cowen · Buy → Buy
- Oct 30, 2026Rating: Citigroup · Buy → Buy
Signals (25)
| Name | Date | Ago |
|---|---|---|
| RSI: Overbought | Nov 3, 2026 | 3 hours ago |
| RSI: Overbought | Oct 26, 2026 | 1 week ago |
| RSI: Overbought | Oct 21, 2026 | 1 week ago |
| MACD: Buy Signal | Oct 15, 2026 | 2 weeks ago |
| MACD: Sell Signal | Oct 7, 2026 | 3 weeks ago |
| MACD: Buy Signal | Oct 5, 2026 | 4 weeks ago |
| MACD: Sell Signal | Oct 2, 2026 | 1 month ago |
| SMA: Bullish | Sep 14, 2026 | 1 month ago |
| SMA: Bullish | Sep 14, 2026 | 1 month ago |
| MACD: Buy Signal | Sep 14, 2026 | 1 month ago |
| SMA: Bearish | Aug 27, 2026 | 2 months ago |
| SMA: Bearish | Aug 27, 2026 | 2 months ago |
| SMA: Bullish | Aug 26, 2026 | 2 months ago |
| SMA: Bullish | Aug 26, 2026 | 2 months ago |
| MACD: Sell Signal | Aug 26, 2026 | 2 months ago |
| SMA: Bearish | Aug 25, 2026 | 2 months ago |
| SMA: Bearish | Aug 25, 2026 | 2 months ago |
| MACD: Buy Signal | Aug 20, 2026 | 2 months ago |
| SMA: Bullish | Aug 19, 2026 | 2 months ago |
| SMA: Bearish | Aug 13, 2026 | 2 months ago |
Newest 20 of 25.
Analyst view
Consensus: strong buy
Strong buy
Price target (mean) 466.67 +13.4% upside
Now 411.51
- Target (low)
- 340.00
- Target (mean)
- 466.67
- Target (high)
- 500.00
Ratings (0m) 16 15 buy · 0 hold · 1 sell
- Strong buy3
- Buy12
- Hold0
- Sell0
- Strong sell1
Recommendation trend
- This month 16
- 1 month ago 17
- 2 months ago 16
Earnings and revenue estimates
Consensus for the coming quarters and fiscal years
| Period | EPS estimate | Low – high | Year ago | EPS growth | Revenue estimate | Revenue growth | Analysts |
|---|---|---|---|---|---|---|---|
| Current quarter | 2.28 | 2.23 – 2.32 | 2.04 | +11.9% | 824.87M | +2.5% | 12 |
| Next quarter | 2.35 | 2.31 – 2.40 | 2.13 | +10.2% | 859.21M | +1.7% | 6 |
| Current year | 9.49 | 9.40 – 9.88 | 7.29 | +30.1% | 3.42B | +11.3% | 16 |
| Next year | 10.32 | 9.19 – 11.08 | 9.49 | +8.8% | 3.62B | +6.0% | 16 |
Upgrades and downgrades
The latest rating changes
| Date | Firm | Action | From | To |
|---|---|---|---|---|
| Oct 30, 2026 | Citigroup | Maintained | Buy | Buy |
| Oct 30, 2026 | TD Cowen | Maintained | Buy | Buy |
| Oct 30, 2026 | Barclays | Maintained | Overweight | Overweight |
| Oct 30, 2026 | Evercore ISI Group | Maintained | Outperform | Outperform |
| Oct 13, 2026 | TD Cowen | Maintained | Buy | Buy |
| Oct 7, 2026 | Barclays | Maintained | Overweight | Overweight |
| Sep 22, 2026 | Morgan Stanley | Upgrade | Equal-Weight | Overweight |
| Sep 9, 2026 | UBS | Maintained | Buy | Buy |
| Aug 3, 2026 | Citigroup | Maintained | Buy | Buy |
| Jul 27, 2026 | Evercore ISI Group | Maintained | Outperform | Outperform |
| Jul 13, 2026 | BNP Paribas | Initiated | — | Outperform |
| Jul 9, 2026 | Morgan Stanley | Maintained | Equal-Weight | Equal-Weight |
| Jul 6, 2026 | Evercore ISI Group | Maintained | Outperform | Outperform |
| Jul 2, 2026 | Keybanc | Maintained | Overweight | Overweight |
| Jun 9, 2026 | Barclays | Upgrade | Equal-Weight | Overweight |
| Jun 2, 2026 | Stephens & Co. | Reiterated | Overweight | Overweight |
| May 29, 2026 | Morgan Stanley | Maintained | Equal-Weight | Equal-Weight |
| Apr 27, 2026 | Barclays | Maintained | Equal-Weight | Equal-Weight |
| Apr 14, 2026 | Barclays | Maintained | Equal-Weight | Equal-Weight |
| Feb 13, 2026 | Barclays | Maintained | Equal-Weight | Equal-Weight |
| Feb 3, 2026 | Evercore ISI Group | Maintained | Outperform | Outperform |
| Dec 2, 2025 | Morgan Stanley | Initiated | — | Equal-Weight |
| Oct 29, 2025 | TD Cowen | Initiated | — | Buy |
| Oct 27, 2025 | Barclays | Maintained | Equal-Weight | Equal-Weight |
| Oct 24, 2025 | UBS | Maintained | Buy | Buy |
| Oct 24, 2025 | Keybanc | Maintained | Overweight | Overweight |
| Oct 23, 2025 | Evercore ISI Group | Maintained | Outperform | Outperform |
| Oct 2, 2025 | Barclays | Maintained | Equal-Weight | Equal-Weight |
| Sep 15, 2025 | Rothschild & Co | Initiated | — | Buy |
| Jul 25, 2025 | UBS | Maintained | Buy | Buy |